GSA Capital Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

GSA Capital Partners’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-230,292	Closed	-$161K	–	2061
2023 Q1	$161K	Sell	230,292 -46,111	-17%	-$37.4K	0.02%	1296
2022 Q4	$227K	Buy	276,403 +156,020	+130%	+$154K	0.03%	1109
2022 Q3	$125K	Buy	120,383 +59,794	+99%	+$95.6K	0.02%	1329
2022 Q2	$99K	Buy	60,589 +33,021	+120%	+$68.6K	0.01%	1222
2022 Q1	$81K	Buy	+27,568	New	+$96.6K	0.01%	1315
2021 Q3	–	Sell	-115,147	Closed	-$859K	–	1876
2021 Q2	$859K	Buy	+115,147	New	+$887K	0.1%	323
2021 Q1	–	Sell	-26,724	Closed	-$247K	–	1601
2020 Q4	$247K	Buy	+26,724	New	+$232K	0.04%	856

Other funds holding SURF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GSA Capital Partners's SURF Position: Q2 2023 in Review

GSA Capital Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 230,292 shares — an estimated $161K sold.

GSA Capital Partners first reported a position in SURF in Q4 2020 and held it in 7 quarters. The position peaked at $859K in Q2 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

GSA Capital Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
GSA Capital Partners sold 230,292 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $161K.
GSA Capital Partners first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
GSA Capital Partners's Surface Oncology, Inc. Common Stock position peaked at $859K in Q2 2021.
61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.